🏛️ Verified NIH Record • Updated 2026-03-31
A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) (NCT03477604)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Micro Medical Solution, Inc.
🩺 Plain-English Summary (8th-Grade Level)
Randomized multicenter clinical trial consisting of two arms; one arm treated with PTA plus the MicroStent® System and one arm treated with PTA alone. Purpose to evaluate the safety and effectiveness of using the MicroStent® Peripheral Vascular Stent System, hereafter referred to as the MicroStent® System, for the treatment of infrapopliteal lesions in subjects with peripheral arterial disease.
Who can join: Review the eligibility criteria below.
Location: Cardiovascular Associates of the Southeast — Birmingham, Alabama
Age range: 21 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (21 Sites)
- Cardiovascular Associates of the Southeast — Birmingham, Alabama
- Copper State Vascular — Mesa, Arizona
- St. Helena Hospital — St. Helena, California
- Rocky Mountain Regional VA Medical Center — Aurora, Colorado
- Palm Vascular — Fort Lauderdale, Florida
- First Coast Cardiovascular Institute — Jacksonville, Florida
- FHV Health — Leesburg, Florida
- Mount Sinai Medical Center — Miami Beach, Florida
- Advent Health Sebring — Sebring, Florida
- Vascular Institute of the Midwest — Davenport, Iowa
- Cardiovascular Institute of the South — Houma, Louisiana
- University of Maryland - Baltimore — Baltimore, Maryland
- Advanced Cardiac and Vascular Amputation Prevention Centers — Grand Rapids, Michigan
- Deborah Heart and Lung Center — Browns Mills, New Jersey
- North Jersey Vascular Center — Clifton, New Jersey
- AMI Vascular Institute — Galloway, New Jersey
- US Cardiovascular — Jefferson Hills, Pennsylvania
- Brown University — Providence, Rhode Island
- Cardiology Consultants — Spartanburg, South Carolina
- Cardiothoracic and Vascular Surgeons — Austin, Texas
- AZH/WAVE Vascular Center — Milwaukee, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Arterial Disease
- SELUTION4SFA Trial — Little Rock, Arkansas
- SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — New Haven, Connecticut
- Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy — Indianapolis, Indiana
- FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease — Chicago, Illinois
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology — Omaha, Nebraska
Explore by condition: All Peripheral Arterial Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.